Energy & environment · 21/12/2007
Mallinckrodt Inc. Seeks License Amendment and Requests Hearing Opportunity
Mallinckrodt Inc., a pharmaceutical company based in St. Louis, Missouri, has submitted a request to the relevant authorities to amend its license and is also seeking the opportunity to request a hearing on the matter.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →